Sarah Jefferies

ORCID: 0000-0001-7660-4466
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Glioma Diagnosis and Treatment
  • Meningioma and schwannoma management
  • Brain Metastases and Treatment
  • Head and Neck Cancer Studies
  • Advanced Radiotherapy Techniques
  • Radiomics and Machine Learning in Medical Imaging
  • COVID-19 epidemiological studies
  • Bone Tumor Diagnosis and Treatments
  • Cancer Research and Treatments
  • Sarcoma Diagnosis and Treatment
  • Cancer, Hypoxia, and Metabolism
  • Neurofibromatosis and Schwannoma Cases
  • Medical Imaging Techniques and Applications
  • Pituitary Gland Disorders and Treatments
  • Influenza Virus Research Studies
  • Neuroblastoma Research and Treatments
  • Head and Neck Surgical Oncology
  • Lung Cancer Treatments and Mutations
  • SARS-CoV-2 and COVID-19 Research
  • Management of metastatic bone disease
  • Respiratory viral infections research
  • Thyroid Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses

Addenbrooke's Hospital
2015-2024

Cambridge University Hospitals NHS Foundation Trust
2014-2024

Institute of Environmental Science and Research
2020-2024

University of Cambridge
2007-2023

Bridge University
2023

National Health Service
2015-2022

Africa Centres for Disease Control and Prevention
2022

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
2019

Hutchison/MRC Research Centre
2018

Queen Mary University of London
2018

Xerostomia is the most common late side-effect of radiotherapy to head and neck. Compared with conventional radiotherapy, intensity-modulated (IMRT) can reduce irradiation parotid glands. We assessed hypothesis that parotid-sparing IMRT reduces incidence severe xerostomia.We undertook a randomised controlled trial between Jan 21, 2003, Dec 7, 2007, compared (control) IMRT. randomly assigned patients histologically confirmed pharyngeal squamous-cell carcinoma (T1-4, N0-3, M0) at six UK...

10.1016/s1470-2045(10)70290-4 article EN cc-by The Lancet Oncology 2011-01-14

To perform a two-cohort, phase I safety and immunogenicity study of IMA950 in addition to standard chemoradiotherapy adjuvant temozolomide patients with newly diagnosed glioblastoma. is novel glioblastoma-specific therapeutic vaccine containing 11 tumor-associated peptides (TUMAP), identified on human leukocyte antigen (HLA) surface receptors primary glioblastoma tissue.

10.1158/1078-0432.ccr-16-0506 article EN Clinical Cancer Research 2016-05-26

Abstract New Zealand, a geographically remote Pacific island with easily sealable borders, implemented nationwide ‘lockdown’ of all non-essential services to curb the spread COVID-19. Here, we generate 649 SARS-CoV-2 genome sequences from infected patients in Zealand samples collected during ‘first wave’, representing 56% confirmed cases this time period. Despite its remoteness, viruses imported into represented nearly genomic diversity sequenced global virus population. These data helped...

10.1038/s41467-020-20235-8 article EN cc-by Nature Communications 2020-12-11

The poly(ADP-ribose) polymerase (PARP) inhibitor olaparib potentiated radiation and temozolomide (TMZ) chemotherapy in preclinical glioblastoma models but brain penetration was poor. Clinically, PARP inhibitors exacerbate the hematological side effects of TMZ. OPARATIC trial conducted to measure recurrent by assess safety tolerability its combination with

10.1093/neuonc/noaa104 article EN cc-by Neuro-Oncology 2020-04-23

Abstract Background New Zealand's (NZ) complete absence of community transmission influenza and respiratory syncytial virus (RSV) after May 2020, likely due to COVID‐19 elimination measures, provided a rare opportunity assess the impact border restrictions on common viral infections over ensuing 2 years. Methods We collected data from multiple surveillance systems, including hospital‐based severe acute infection surveillance, SHIVERS‐II, ‐III ‐IV cohorts for (ARI) HealthStat sentinel general...

10.1111/irv.13247 article EN cc-by Influenza and Other Respiratory Viruses 2024-02-01

Abstract Purpose: Patients with recurrent high-grade gliomas (HGG) are usually managed alkylating chemotherapy ± bevacizumab. However, prognosis remains very poor. Preclinically, we showed that HGGs a target for arginine depletion pegargiminase (ADI-PEG20) due to epimutations of argininosuccinate synthetase (ASS1) and/or lyase (ASL). Moreover, ADI-PEG20 disrupts pyrimidine pools in ASS1-deficient HGGs, thereby impacting sensitivity the antifolate, pemetrexed. and Methods: We expanded phase I...

10.1158/1078-0432.ccr-18-3729 article EN Clinical Cancer Research 2019-02-22
D. Gareth Evans Dorothy Halliday Rupert Obholzer Shazia Afridi Claire Forde and 95 more Scott Rutherford Charlotte Hammerbeck-Ward Simon Lloyd Simon Freeman Omar Pathmanaban Owen Thomas Roger Laitt Stavros Stivaros John‐Paul Kilday Grace Vassallo Catherine McBain Timothy Lavin Chay Paterson Gillian Whitfield Martin G. McCabe Patrick Axon Jane Halliday Samuel MacKeith Allyson Parry Patrick Axon Juliette Buttimore James R. Tysome Neil Donnelly Daniele Borsetto James Whitworth Anke Hensiek R. Jena Mathew R. Guilfoyle Richard Mannion James Nicholson Brinda Muthusamy Amy Taylor Richard D. Price Karine Edme Nicola Gamazo Zebunnisa Vanat Daniel Scoffings Josh Scott Sarah Jefferies Richard Knight Tamara Lamb Yu Chuen Tam K. Foweraker Fiona Harris Paul Sanghera Sara Meade Richard Irving Peter Monksfield Nicola Ragge Melanie Murrell Julian Barwell Martin English Rikin Trivedi Shazia Afridi Rosalie E. Ferner Rupert Obholzer Victoria Williams Chris Hammond Karine Lascelles Chris Skilbeck Adam Shaw Angela Swampillai Suki Thomson Nicholas J. Thomas Eleni Maratos Sinan Barazi Rebecca Mullin Susie M.D. Henley Natalie Smith Lal Carlton-Jones Alison Baker Mandy Myers Terry Nunn Charles Nduka Raji Anup Chris Duff Simon Freeman Nicola Jarvis Ian Kamaly-Asl Andrew T. King Mark Kellett John‐Paul Kilday Simon Lloyd Catherine McBain Roger Laitt Martin O’Driscoll Martin G. McCabe Mary Perry Scott Rutherford K. Henshaw Stavros Stivaros Owen Thomas Grace Vassallo Charlotte Hammerbeck-Ward Omar Pathmanaban

Abstract Background Radiation treatment of benign tumors in tumor predisposition syndromes is controversial, but short-term studies from centers suggest safety despite apparent radiation-associated malignancy being reported. We determined whether radiation NF2-related schwannomatosis patients associated with increased rates subsequent (M)/malignant progression (MP). Methods All UK NF2 were eligible if they had a clinical/molecular diagnosis. Cases treated for tumors. Controls matched...

10.1093/noajnl/vdad025 article EN cc-by Neuro-Oncology Advances 2023-01-01

Glioblastoma has a dismal prognosis and molecular targeted agents have failed to improve outcomes date. PARADIGM-2 is phase I dose escalation study evaluating olaparib plus radiotherapy ± temozolomide in newly diagnosed glioblastoma, using MGMT methylation status stratify patients inform treatment schedules.

10.1016/j.ctro.2017.11.003 article EN cc-by Clinical and Translational Radiation Oncology 2017-11-21

Abstract Real-time genomic sequencing has played a major role in tracking the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), contributing greatly to disease mitigation strategies. In August 2020, after having eliminated virus, New Zealand experienced second outbreak. During that outbreak, used primary role, leading elimination virus. We generated genomes from 78% laboratory-confirmed samples SARS-CoV-2 outbreak and compared them with available data. Genomic...

10.3201/eid2705.204579 article EN cc-by Emerging infectious diseases 2021-04-27

Purpose To evaluate glioblastoma (GBM) metabolism by using hyperpolarized carbon 13 (13C) MRI to monitor the exchange of 13C label between injected [1-13C]pyruvate and tumor lactate bicarbonate. Materials Methods In this prospective study, seven treatment-naive patients (age [mean ± SD], 60 years 11; five men) with GBM were imaged at 3 T a dual-tuned 13C–hydrogen 1 head coil. Hyperpolarized was injected, signal acquired dynamic spiral sequence. Metabolism assessed within tumor, in...

10.1148/rycan.210076 article EN Radiology Imaging Cancer 2022-07-01
Coming Soon ...